Periodic Reporting for period 3 - PD-MIND (Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug)

Summary
Parkinson Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease. There is an unmet clinical need to treat Parkinson disease with mild cognitive impairment (PD-MCI), i.e. Parkinson patients whose cognition is impaired, but who have not yet...
More information & hyperlinks
Web resources: http://www.pd-mind.org